Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 6
2004 3
2005 3
2006 6
2007 2
2008 2
2009 9
2010 5
2011 11
2012 7
2013 9
2014 10
2015 12
2016 7
2017 11
2018 8
2019 7
2020 18
2021 13
2022 11
2023 23
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

177 results

Results by year

Filters applied: . Clear all
Page 1
ETV6::NTRK3 Fusion-Positive Wild-Type Gastrointestinal Stromal Tumor (GIST) with Abundant Lymphoid Infiltration (TILs and Tertiary Lymphoid Structures): A Report on a New Case with Therapeutic Implications and a Literature Review.
Machado I, Claramunt-Alonso R, Lavernia J, Romero I, Barrios M, Safont MJ, Santonja N, Navarro L, López-Guerrero JA, Llombart-Bosch A. Machado I, et al. Int J Mol Sci. 2024 Mar 26;25(7):3707. doi: 10.3390/ijms25073707. Int J Mol Sci. 2024. PMID: 38612518 Free PMC article. Review.
Primary renal epithelioid dedifferentiated liposarcoma mimicking a GLI1-amplified neoplasm.
Machado I, Abaunz AJ, Claramunt R, Silva TM, Romagosa C, Sesé M, Hernandez-Losa J, López-Guerrero JA, Llombart-Bosch A. Machado I, et al. Among authors: lopez guerrero ja. Pathol Res Pract. 2024 Apr 2;257:155279. doi: 10.1016/j.prp.2024.155279. Online ahead of print. Pathol Res Pract. 2024. PMID: 38608370 No abstract available.
Phase II Trial Evaluating Olaparib Maintenance in Patients with Metastatic Castration-Resistant Prostate Cancer Responsive or Stabilized on Docetaxel Treatment: SOGUG-IMANOL Study.
Juan Fita MJ, Anido Herranz U, Mendez-Vidal MJ, Gironés-Sarrió R, Muñoz-Langa J, Sepúlveda-Sánchez J, Mellado B, Alvarez-Fernandez C, Heras López L, López-Guerrero JA, García-Casado Z, Calatrava A, Ángel Climent M. Juan Fita MJ, et al. Cancers (Basel). 2023 Oct 31;15(21):5223. doi: 10.3390/cancers15215223. Cancers (Basel). 2023. PMID: 37958398 Free PMC article.
Primary Rectal Tumor With Extensive Choriocarcinoma Differentiation in a Woman With Lung, Liver and Disseminated Peritoneal Disease: A Primary Rectal Adenocarcinoma With Extensive Choriocarcinoma Differentiation or Primary Rectal Choriocarcinoma?
Machado I, Martínez La Piedra MDC, Martínez de Juan F, de Alcántara FM, Claramunt R, López-Guerrero JA, Marhuenda A, Melian M. Machado I, et al. Int J Surg Pathol. 2023 Oct 26:10668969231204956. doi: 10.1177/10668969231204956. Online ahead of print. Int J Surg Pathol. 2023. PMID: 37885271
2023 GEIS Guidelines for gastrointestinal stromal tumors.
Serrano C, Martín-Broto J, Asencio-Pascual JM, López-Guerrero JA, Rubió-Casadevall J, Bagué S, García-Del-Muro X, Fernández-Hernández JÁ, Herrero L, López-Pousa A, Poveda A, Martínez-Marín V. Serrano C, et al. Ther Adv Med Oncol. 2023 Aug 24;15:17588359231192388. doi: 10.1177/17588359231192388. eCollection 2023. Ther Adv Med Oncol. 2023. PMID: 37655207 Free PMC article. Review.
REGISTRI: Regorafenib in first-line of KIT/PDGFRA wild type metastatic GIST: a collaborative Spanish (GEIS), Italian (ISG) and French Sarcoma Group (FSG) phase II trial.
Martin-Broto J, Valverde C, Hindi N, Vincenzi B, Martinez-Trufero J, Grignani G, Italiano A, Lavernia J, Vallejo A, Tos PD, Le Loarer F, Gonzalez-Campora R, Ramos R, Hernández-Jover D, Gutierrez A, Serrano C, Monteagudo M, Letón R, Robledo M, Moura DS, Martin-Ruiz M, López-Guerrero JA, Cruz J, Fernandez-Serra A, Blay JY, Fumagalli E, Martinez-Marin V. Martin-Broto J, et al. Among authors: lopez guerrero ja. Mol Cancer. 2023 Aug 9;22(1):127. doi: 10.1186/s12943-023-01832-9. Mol Cancer. 2023. PMID: 37559050 Free PMC article. Clinical Trial.
USP1 Expression Driven by EWS::FLI1 Transcription Factor Stabilizes Survivin and Mitigates Replication Stress in Ewing Sarcoma.
Mallard HJ, Wan S, Nidhi P, Hanscom-Trofy YD, Mohapatra B, Woods NT, Lopez-Guerrero JA, Llombart-Bosch A, Machado I, Scotlandi K, Kreiling NF, Perry MC, Mirza S, Coulter DW, Band V, Band H, Ghosal G. Mallard HJ, et al. Mol Cancer Res. 2023 Nov 1;21(11):1186-1204. doi: 10.1158/1541-7786.MCR-23-0323. Mol Cancer Res. 2023. PMID: 37478161 Free PMC article.
177 results